feed,title,long_url,short_url
InvestorPlace,Ocugen Latest News: What OCGN Stock Investors Need to Know About the FDA’s Covaxin Rejection,https://investorplace.com/2022/03/ocugen-latest-news-what-ocgn-stock-investors-need-to-know-about-the-fdas-covaxin-rejection/,https://bit.ly/3MmiVBA
InvestorPlace,Intel’s New Dividend and Its High Dividend Yield Imply Good Value for INTC Stock,https://investorplace.com/2022/03/intc-stock-might-rise-to-close-to-60-as-its-average-dividend-yield-is-lower-than-today/,https://bit.ly/3IMGnWy
